Latest Breaking News On - Praveen tipirneni - Page 1 : comparemela.com

Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024

-Enrollment continued on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis-

Simon cooperChris erdmanPraveen tipirneniKey additions to morphic leadership teamDevelopment programNapp pharmaceutical researchExchange commissionUniversity of newcastle upon tyne medical schoolMorphic holding incWyeth researchHuman genome sciencesKadmon holdingsSecurities exchangeChief medicalChief medical officerRecent corporate

Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023

-Reported positive results from EMERALD-1 phase 2a trial of MORF-057 in ulcerative colitis - -Enrollment on target in EMERALD-2 phase 2b global randomized trial of MORF-057 in UC- .

Praveen tipirneniChris erdmanMorphic holding incSecurities exchangeExchange commissionGlobenewswire incChief executive officerRecent corporate highlightsRobarts histopathology indexMayo clinic scoreSimple endoscopic scoreFull yearModified mayo clinic scoreDisease activity indexSecurities actSecurities exchange act

Morphic Holding Inc CEO Praveen Tipirneni Sells 13,923 Shares

On January 16, 2024, CEO of Morphic Holding Inc (NASDAQ:MORF), Praveen Tipirneni, sold 13,923 shares of the company, according to a recent SEC Filing.

Morphic holding incIopharmaceutical companyPraveen tipirneni

Morphic to Present at the 42nd Annual J P Morgan Healthcare Conference

03.01.2024 - -Dr. Praveen Tipirneni, returns in full capacity as Chief Executive Officer from medical leave- WALTHAM, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) - Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral .

Praveen tipirneniChief executive officerHealthcare conferenceMorphic holding chartOrphic holding kursOrphic holding aktie

Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023

Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPraveen tipirneniContactsmorphic therapeuticchris erdmanBruce rogersDevelopment program updatesExchange commissionMorphic holding incSecurities exchangeRecent corporateExecutive officerMorphic therapeuticThird quarterRobarts histopathology indexModified mayo clinic scoreMorphic therapeuticmorphic therapeuticNote regarding forward looking statementsthis